Literature DB >> 15010289

Antibodies to highly conserved peptide sequence of staphylococcal and streptococcal superantigens in Kawasaki disease.

Monesha Gupta-Malhotra1, Anne Viteri-Jackson, William Thomas, John B Zabriskie.   

Abstract

Superantigen-mediated disease such as toxic shock syndrome is seen in patients who have a weak antibody response to the antigen toxic shock syndrome toxin 1 (TSST-1). We hypothesized that there may be deficiency in antibody production to staphylococcal and streptococcal toxins in Kawasaki disease (KD) children. A peptide was constructed from the homologous portion of the staphylococcal enterotoxins (SE) and streptococcal pyrogenic enterotoxins (SPE), and antibodies to the peptide were made. The anti-peptide antibody immunoblotted several of the SE toxins and SPE toxins. Presence of the peptide antibodies was investigated via ELISA in the sera of acute KD (n = 30), convalescent KD (n = 12), control adults (n = 10), and children (n = 19). The mean anti-peptide antibodies were indistinguishable between control children and KD before treatment with immunoglobulin (P = 0.7) but rose significantly after therapy (P < 0.01). The adults had significantly higher antibodies than the KD, both acute and late (P < 0.0001) and the control children (P < 0.0001). Thus, KD patients do not have a defective serological response against toxins such as SPE/SE/TSST-1. Normal children have significantly lower antitoxin antibody levels to the toxins compared to the adults.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15010289     DOI: 10.1016/j.yexmp.2003.12.003

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  5 in total

1.  Involvement of innate and adaptive immunity in a murine model of coronary arteritis mimicking Kawasaki disease.

Authors:  Danica J Schulte; Atilla Yilmaz; Kenichi Shimada; Michael C Fishbein; Emily L Lowe; Shuang Chen; Michelle Wong; Terence M Doherty; Thomas Lehman; Timothy R Crother; Rosalinda Sorrentino; Moshe Arditi
Journal:  J Immunol       Date:  2009-09-28       Impact factor: 5.422

Review 2.  Pathogenetic determinants in Kawasaki disease: the haematological point of view.

Authors:  Domenico Del Principe; Donatella Pietraforte; Lucrezia Gambardella; Alessandra Marchesi; Isabella Tarissi de Jacobis; Alberto Villani; Walter Malorni; Elisabetta Straface
Journal:  J Cell Mol Med       Date:  2017-01-07       Impact factor: 5.310

Review 3.  Kawasaki Disease: The Role of Immune Complexes Revisited.

Authors:  Stephanie Menikou; Paul R Langford; Michael Levin
Journal:  Front Immunol       Date:  2019-06-12       Impact factor: 7.561

Review 4.  Searching for the cause of Kawasaki disease--cytoplasmic inclusion bodies provide new insight.

Authors:  Anne H Rowley; Susan C Baker; Jan M Orenstein; Stanford T Shulman
Journal:  Nat Rev Microbiol       Date:  2008-05       Impact factor: 60.633

Review 5.  Current perspectives on Kawasaki disease.

Authors:  Monesha Gupta-Malhotra; P Syamasundar Rao
Journal:  Indian J Pediatr       Date:  2005-07       Impact factor: 1.967

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.